Explore 3 Stock Ideas & Industry Insights Download Free Report

Paragon 28 Inc

Company price
None USD 0.00(0%)
Last update at 2025-05-19T13:01:28.766833Z
Market Cap
971.74M

Momentum Score

…

Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
7.95
Low
21.49
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
207.34M
Revenue Per Share
2.57
Gross Profit TTM
148.93M
Debt / Equity
0.30
ROE
-36.73%
Net Debt
4.44M
ROCE
-18.88%
Diluted EPS TTM
-0.86

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -67.39M -12.98M 5.03M 1.97M
Net income -67.33M -13.69M 3.50M 3.12M
Selling general administrative 159.32M 114.09M 72.64M 74.44M
Gross profit 148.93M 119.44M 85.88M 87.45M
Reconciled depreciation 13.73M 8.96M 6.38M 4.20M
Ebit -35.05M -10.78M 5.63M 2.72M
Ebitda -22.53M -2.30M 12.01M 6.82M
Depreciation and amortization 12.51M 8.47M 6.38M 4.10M
Non operating income net other -1.21M -0.49M - -
Operating income -35.05M -10.78M 5.63M 2.72M
Other operating expenses 216.43M 158.24M 108.91M 103.56M
Interest expense 4.13M 1.72M 0.60M 0.65M
Tax provision -0.06M 0.71M 1.53M -1.15M
Interest income 4.13M 1.72M 0.60M 0.65M
Net interest income -4.13M -1.72M -0.60M -0.65M
Income tax expense -0.06M 0.71M 1.53M -1.15M
Total revenue 181.38M 147.46M 110.98M 106.28M
Total operating expenses 183.97M 130.22M 83.81M 84.73M
Cost of revenue 32.46M 28.02M 25.10M 18.83M
Total other income expense net -32.34M -2.21M -0.60M -0.75M
Net income from continuing ops -67.33M -13.69M 3.50M 3.12M
Net income applicable to common shares -67.33M -13.69M 2.69M 3.12M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 254.11M 234.54M 97.58M 74.56M
Intangible assets 22.39M 16.50M 3.33M 2.29M
Other current assets 4.66M 3.08M 0.62M 1.55M
Total liab 113.18M 42.35M 26.10M 47.31M
Total stockholder equity 140.93M 192.19M 71.48M 27.25M
Deferred long term liab 0.34M 0.08M - -
Other current liab 52.69M 1.93M 0.47M 0.45M
Common stock 0.78M 0.76M 0.09M 0.08M
Capital stock 0.78M 0.76M 41.19M 4.33M
Retained earnings -67.79M -0.46M 12.42M 9.73M
Other liab 1.12M 0.92M - -
Good will 25.46M 6.33M - -
Other assets 0.15M 0.00M 0.10M 1.41M
Cash 38.47M 109.35M 17.50M 2.61M
Total current liabilities 68.50M 33.96M 22.07M 47.23M
Current deferred revenue 0.15M 18.85M 10.56M 11.62M
Net debt 4.44M -101.72M -11.24M 17.59M
Short term debt 0.73M 0.15M 2.23M 20.13M
Short long term debt 0.73M 0.15M 2.23M 20.13M
Short long term debt total 42.91M 7.63M 6.26M 20.20M
Other stockholder equity 207.97M -42.66M 17.06M 13.18M
Property plant equipment 61.94M 32.18M 22.36M 19.83M
Total current assets 142.38M 179.53M 71.80M 51.03M
Net tangible assets 93.08M 169.36M 27.07M 20.71M
Net receivables 38.30M 26.86M 21.45M 22.28M
Long term debt 42.18M 7.48M 4.03M 0.07M
Inventory 60.95M 40.24M 32.23M 24.58M
Accounts payable 14.94M 13.03M 8.81M 15.04M
Accumulated other comprehensive income -0.03M 0.01M 0.82M 0.01M
Common stock total equity 0.78M 0.76M - -
Retained earnings total equity -67.79M -0.46M - -
Treasury stock - -5.98M -5.42M -3.88M
Non currrent assets other 1.79M -0.08M - -
Non current assets total 111.73M 55.02M 25.79M 23.53M
Long term debt total 42.18M 7.48M 4.03M 0.07M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -60.69M -35.49M -10.32M -17.45M
Change to liabilities 4.07M 7.77M -6.24M 8.43M
Total cashflows from investing activities -60.69M -35.49M -10.32M -17.45M
Net borrowings 34.70M 0.83M -14.05M 10.46M
Total cash from financing activities 39.49M 131.10M 24.01M 6.54M
Change to operating activities 22.67M 4.63M 0.13M 2.48M
Net income -67.33M -13.69M 3.50M 3.12M
Change in cash -70.88M 91.85M 14.89M 1.42M
Begin period cash flow 109.35M 17.50M 2.61M 1.19M
End period cash flow 38.47M 109.35M 17.50M 2.61M
Total cash from operating activities -49.18M -3.32M 1.11M 12.30M
Issuance of capital stock 0.00M 130.38M 37.87M 0.00M
Depreciation 13.73M 8.96M 6.38M 4.20M
Other cashflows from investing activities -60.69M -17.19M 0.52M 0.58M
Dividends paid - 10.45M 38.27M -
Change to inventory -21.51M -11.10M -14.83M -3.56M
Change to account receivables -12.01M -6.46M 0.39M -5.22M
Sale purchase of stock 5.79M -0.56M -1.54M -3.88M
Other cashflows from financing activities 34.79M 17.75M 76.48M 12.63M
Change to netincome 11.69M 9.23M 11.88M 3.17M
Capital expenditures 43.09M 21.29M 10.84M 18.03M
Change receivables -12.01M -6.46M - -
Cash flows other operating 21.58M 1.40M - -
Exchange rate changes - -0.44M - -
Cash and cash equivalents changes -70.39M 91.85M - -
Change in working capital -8.57M -8.83M -20.79M 1.72M
Stock based compensation 10.37M 4.95M 1.81M 1.75M
Other non cash items 3.14M 5.13M 8.90M 2.62M
Free cash flow -92.27M -24.61M -9.73M -5.74M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
ABT
Abbott Laboratories
1.27
1.18%
108.52 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC
1.87
1.85%
102.86 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation
-2.75
0.88%
309.64 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG
-0.27
0.55%
48.51 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Paragon 28 Inc

Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.

14445 Grasslands Drive, Englewood, CO, United States, 80112

730 399 3400

463

Name Title Year Born
Mr. Albert DaCosta Co-Founder, Chairman & CEO 1974
Mr. Stephen M. Deitsch CFO & Principal Fin. Officer 1971
Mr. Matthew Jarboe Chief Commercial Officer 1984
Mr. Jeff Sears VP of Operations NA
Mr. Erik Mickelson Chief Accounting Officer & Controller NA
Jason Edie Chief Technology Officer NA
Matt Brinckman Sr. VP of Strategy & Investor Relations NA
Ms. Michelle Missal VP & Chief Compliance Officer NA
Mr. Jonathan Friedman Gen. Counsel & Sec. 1971
Mr. John Shumaker Exec. VP of Sales - U.S. NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…